Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2017-06-13 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Goldman Sachs 38th Annual Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document text is a presentation slide deck structure, featuring company overviews, segment details (Fresenius Medical Care, Kabi, Helios, Vamed), financial tables, growth drivers, and outlooks. It specifically references 'Q1/2017 Actual' data and provides a '2017e New' outlook, indicating it is a report summarizing recent quarterly performance and providing forward guidance. The content is highly detailed and analytical, characteristic of an Investor Presentation (IP) or a Management Discussion and Analysis (MDA) section, but the format strongly suggests a presentation deck used for investor briefings. Since it contains detailed segment performance, financial tables, and outlooks, 'Investor Presentation' (IP) is the most appropriate classification over a simple Earnings Release (ER) or a comprehensive Interim Report (IR), which are usually regulatory filings rather than presentation materials.
2017-06-13 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German securities law (WpHG). It details changes in voting rights held by BlackRock, Inc., crossing a threshold (5.02% resulting situation). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a specific disclosure of shareholding changes, which aligns best with MRQ.
2017-06-09 English
Barclays High Yield Bond and Syndicated Loan Conference
Investor Presentation Classification · 98% confidence The document is a presentation titled 'Barclays - High Yield Bond and Syndicated Loan Conference June 8, 2017'. It contains an agenda covering company overview, business segments, financial overview, financing facilities, and M&A activity (Acquisition of Akorn, Inc. & Merck KGaA's Biosimilars Business). It includes detailed financial figures for Q1/2017 and full-year 2016 for various segments, along with growth drivers and market dynamics. This structure is characteristic of an Investor Presentation (IP) given at a conference, designed to convey strategy, performance, and outlook to investors and the financial community. It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), but rather a detailed presentation package.
2017-06-08 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' regarding BlackRock, Inc.'s acquisition/disposal of shares in Fresenius SE & Co. KGaA, crossing a threshold on 01 Jun 2017. This content directly corresponds to regulatory filings concerning changes in significant share ownership. The definition for Major Shareholding Notification (MRQ) is 'Notification of changes in significant share ownership levels (crossing thresholds)'. Although it is disseminated via DGAP, which often carries general regulatory news (RNS), the specific content is a direct notification of a major holding change, making MRQ the most precise classification.
2017-06-07 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: Fresenius SE & Co. KGaA english' and contains the header 'Directors’ Dealings'. Section 2 is titled 'Reason for the notification' and Section 4 details 'Details of the transaction(s)' involving a 'Member of the managing body' (Director/Executive) and the nature of the transaction is the 'Exercise of options on Fresenius shares... and sale of the shares'. This content directly corresponds to the definition of Director's Dealing reports.
2017-06-07 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Total Voting Rights Announcement' issued by Fresenius SE & Co. KGaA, referencing Article 26a of the WpHG (German Securities Trading Act). It explicitly details a 'Type of capital measure' which is a 'Conditional capital increase' and states the 'New total number of voting rights'. This type of announcement, which reports on changes to the total number of shares/voting rights, fits best under the category related to capital structure changes or specific regulatory disclosures about share counts. While it relates to capital, it is a specific regulatory notification about voting rights rather than a general financing activity (CAP) or a share repurchase (POS). Since it is a specific regulatory disclosure that doesn't fit perfectly into the main financial reports (10-K, IR) or common corporate actions (DIV, SHA), and it is a formal announcement distributed via DGAP, it aligns closely with a specific regulatory filing type. However, given the options, the closest fit for a notification about the total number of shares/voting rights resulting from a capital measure is often grouped with capital changes or general regulatory filings. Since it is a formal notification about the capital structure (voting rights), 'CAP' (Capital/Financing Update) is a possibility, but 'SHA' (Share Issue/Capital Change) is more precise for changes in the number of shares. Since this is a notification of the *total* voting rights following a capital measure, 'SHA' is the most appropriate specific code for a change in the share count/capital structure.
2017-05-31 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.